PTPRC and neoplasm: Immunohistochemistry (IHC) on a single tumor from each involution group revealed increased intratumoral staining for CD45, which was validated by our flow cytometry where we observed a >2-fold increase in the number of CD45+ cells in the tumor (Figures 4C,D).